Oncogenic signaling: new insights and controversies from chronic myeloid leukemia

Por Van Etten, Richard A.
Publicado em 2007

Aberrant Cytokine Signaling in Leukemia

Por Van Etten, Richard A.
Publicado no Oncogene (2007)

Interfering with leukemic stem cells

Por Krause, Daniela S., Van Etten, Richard A.
Publicado em 2008

Signal Transduction in the Chronic Leukemias: Implications for Targeted Therapies

Por Ahmed, Wesam, Van Etten, Richard A.
Publicado em 2013

Right on target: Eradicating leukemic stem cells

Por Krause, Daniela S., Van Etten, Richard A.
Publicado no Trends Mol Med (2007)

Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond

Por Ahmed, Wesam, Van Etten, Richard A.
Publicado no Hematology Am Soc Hematol Educ Program (2013)

The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity

Por Wen, Shih-Te, Van Etten, Richard A.
Publicado em 1997

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Por Gavrilescu, L Cristina, Van Etten, Richard A
Publicado em 2007

Navigating the road towards optimal initial therapy for chronic myeloid leukemia

Por Okimoto, Ross A., Van Etten, Richard A.
Publicado em 2011

IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1

Por Hsieh, Mo-Ying, Van Etten, Richard A.
Publicado em 2014

Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling

Por Li, Shaoguang, Couvillon, Anthony D., Brasher, Bradley B., Van Etten, Richard A.
Publicado em 2001

Comparison of mutated JAK2 and ABL1 as oncogenes and drug targets in myeloproliferative disorders

Por Walz, Christoph, Cross, Nicholas C. P., Van Etten, Richard A., Reiter, Andreas
Publicado em 2008

A Direct Binding Site for Grb2 Contributes to Transformation and Leukemogenesis by the Tel-Abl (ETV6-Abl) Tyrosine Kinase

Por Million, Ryan P., Harakawa, Nari, Roumiantsev, Sergei, Varticovski, Lyuba, Van Etten, Richard A.
Publicado em 2004

Ubiquitous and Uniform In Vivo Fluorescence in ROSA26-EGFP BAC Transgenic Mice

Por Giel-Moloney, Maryann, Krause, Daniela S., Chen, Gang, Van Etten, Richard A., Leiter, Andrew B.
Publicado em 2007

The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity

Por Li, Shaoguang, Ilaria, Robert L., Million, Ryan P., Daley, George Q., Van Etten, Richard A.
Publicado em 1999

Selectins and their ligands are required for homing and engraftment of BCR-ABL1(+) leukemic stem cells in the bone marrow niche

Por Krause, Daniela S., Lazarides, Katherine, Lewis, Juliana B., von Andrian, Ulrich H., Van Etten, Richard A.
Publicado em 2014

Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model

Por Lu, Yi-Fen, Gavrilescu, L. Cristina, Betancur, Monica, Lazarides, Katherine, Klingemann, Hans, Van Etten, Richard A.
Publicado em 2012

Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens

Por Boissel, Laurent, Betancur, Monica, Lu, Weiquan, Wels, Winfried S., Marino, Teresa, Van Etten, Richard A., Klingemann, Hans
Publicado em 2011

Ikaros mutation confers integrin-dependent pre-B cell survival and progression to acute lymphoblastic leukemia

Por Joshi, Ila, Yoshida, Toshimi, Jena, Nilamani, Qi, Xiaoqing, Zhang, Jiangwen, Van Etten, Richard A., Georgopoulos, Katia
Publicado no Nat Immunol (2014)

Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F

Por Zaleskas, Virginia M., Krause, Daniela S., Lazarides, Katherine, Patel, Nihal, Hu, Yiguo, Li, Shaoguang, Van Etten, Richard A.
Publicado em 2006